Brown, Lisle/Cummings, Inc. Boston Scientific Corp Transaction History

Brown, Lisle/Cummings, Inc.

$329 Billion
Q3 2024

A detailed history of Brown, Lisle/Cummings, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 73,692 shares of BSX stock, worth $6.71 Million. This represents 1.88% of its overall portfolio holdings.

Number of Shares

73,692

Previous 73,617 0.1%

Holding current value

$6.71 Million

Previous $5.67 Billion 8.93%

% of portfolio

1.88%

Previous 1.85%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$72.96 - $84.0 $5,471 - $6,300	75 Added 0.1%	73,692 $6.18 Billion
Q2 2024 Jul 17, 2024	BUY	$67.33 - $77.71 $16,832 - $19,427	250 Added 0.34%	73,617 $5.67 Billion
Q1 2024 Jun 28, 2024	BUY	$57.6 - $68.62 $72,000 - $85,775	1,250 Added 1.73%	73,367 $5.02 Billion
Q4 2023 Jun 28, 2024	SELL	$48.64 - $57.81 $4,864 - $5,781	-100 Reduced 0.14%	72,117 $4.17 Billion
Q3 2023 Jun 28, 2024	BUY	$50.19 - $54.68 $126,729 - $138,067	2,525 Added 3.62%	72,217 $3.81 Billion
Q2 2023 Jun 28, 2024	BUY	$49.72 - $54.64 $329,395 - $361,990	6,625 Added 10.5%	69,692 $3.77 Billion
Q1 2023 Jun 28, 2024	BUY	$45.09 - $50.03 $43,962 - $48,779	975 Added 1.57%	63,067 $3.16 Billion
Q4 2022 Jun 28, 2024	BUY	$39.56 - $47.22 $50,439 - $60,205	1,275 Added 2.1%	62,092 $2.87 Billion
Q3 2022 Jun 28, 2024	SELL	$36.71 - $109.66 $36,710 - $109,660	-1,000 Reduced 1.62%	60,817 $2.36 Billion
Q2 2022 Jun 28, 2024	BUY	$35.24 - $47.1 $87,219 - $116,572	2,475 Added 4.17%	61,817 $2.3 Billion
Q1 2022 Jun 28, 2024	BUY	$40.9 - $45.1 $213,702 - $235,647	5,225 Added 9.66%	59,342 $2.63 Billion
Q4 2021 Jun 28, 2024	BUY	$38.07 - $44.87 $2.06 Million - $2.43 Million	54,117 New	54,117 $2.3 Billion

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.

Account

Brown, Lisle/Cummings, Inc. Boston Scientific Corp Transaction History